REFERENCES
- Seaworth BJ. Multidrug-resistant tuberculosis. Infect Dis Clin North Am 2002; 16 (1): 73–107.
- Woods GL. The mycobacteriology laboratory and new diagnostic techniques. Infect Dis Clin North Am 2002; 16: 127–44.
- Lambergts-van Weezenbeek CSB. Drug-resistant tuber-culosis. Eur Respir Mon. 1997; 4: 298–326.
- American Thoracic Society. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000; 161: 1376–95.
- Tahaoglu K, Törün T, Sevim T, et al. The treatment of multidrug-resistant tuberculosis in Turkey. N Eng J Med 2001; 345: 170–4.
- Tahaoglu K, Kizgin Ö, Karagöz T et al. High initial and acquired drug resistance in pulmonary tuberculosis in Turkey. Tubercle Lung Dis 1994; 75: 324–28.
- Guneri S, Unsal I, Oztop A, et al. Drug resistance to tuberculosis in Aegean Region. Toraks Derg. 2002; 3: 77–8.
- Cavusoglu C, Hilmioglu S, Guneri S, et al. Characterization of rpoB mutations in rifampicin-resistant clin-ical isolates of Mycobacterium tuberculosis from Turkey by DNA sequencing and line probe assay. J Clin Microbiol 2002; 40 (12): 4435–8.
- Taylor TB, Patterson C, Hale Y, et al. Routine use of PCR-restriction fragment length polymorphism analysis for identification of mycobacteria growing in liquid media. J Clin Microbiol. 1997; 35: 79–85.
- Canetti G, Fox W, Khomenko A et al. Advances in techniques of testing mycobacterial drug sensitivity and the use of sensitivity tests in Tuberculosis Control Programmes. Bull Wld Hlth Org 1969; 41: 21–43.
- Mani C, Selvakumar N, Narayanan S et al. Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuber-culosis clinical isolates from India. J Clin Microbiol. 2001; 39 (8): 2987-90.
- Ramaswamy S, Musser JM. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tubercle Lung Dis 1998; 79 (1): 3–29
- Morlock GP, Plikaytis BB, Crawford JT. Characterization of spontaneous, in vitro selected, rifampicin-resistant mutants of Mycobacterium tuberculosis strains H37Rv. Antimicrob Agents Chemother 2000; 44 (12): 3298–301.
- Hwang HY, Chang CY, Chang LL, et al. Characterization of rifampicin-resistant Mycobacterium tuber-culosis in Taiwan. J Med Microbiol. 2003; 52 239–45.
- Bartfai Z, Somoskovi A,Kodman C, et al. Molecular characterization of rifampicin-resistant isolates of Mycobacterium tuberculosis from Hungary by DNA sequenc-ing and line probe assay. J Clin Microbiol 2001; 39 (10): 3736–9.
- Miranda SS, Kritski A, Filliol I, et al. Mutations in the rpoB gene of rifampicin-resistant Mycobacterium tuberculosis strains isolated in Brazil and France. Mem Inst Oswaldo Cruz, Rio de Janeiro. 2001; 96 (2), 247–50.
- Valim ARM, Rosetti MLR, Ribeiro MO et al. Mutations in the rpoB Gene of multidrug-resistant Mycobacterium tuberculosis isolates from Brazil. J Clin Microbiol 2000; 38 (8): 3119-22.
- Bobadilla-del-Valle M, Ponce-de-Leon A, Arenas-Huertero C et al. rpoB gene mutations in rifampicin-resistant Mycobacterium tuberculosis identified by polymerase chain reaction single-stranded conformational polymorphism. Emerging Infect Dis 2001; 7 (6): 1010-3.
- Kapur V, Li LL, Iondanescu S, et al. Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase 13 subunit in rifampicin-resistant Mycobacterium tuberculosis strains from New York City and Texas. J Clin Microbiol 1994; 32: 1095–98.